Rayner acquires stake in Reper to boost R&D and Russian presence

Rayner, a UK-based ophthalmic implant manufacturer, has acquired a substantial stake in Reper, a Russian material science and medical device company, following a four-year R&D collaboration on a hydrophobic IOL material. Financial terms are not disclosed.

“Reper became an important partner for Rayner with several new and exciting R&D projects in the pipeline in cataract and beyond.”rayner.com

• 1 source
• rayner.comRayner partners and acquires stake in Reper to drive R&D and build presence in Russia. - Rayner : USAkevinSep 1, 2019

Summarized from public sources; check the original articles before acting on it.